Agios Pharma (AGIO) Misses Q4 EPS by 15c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. META
5. TSLA
6. ISRG
7. SMCI
8. RTX
9. S
10. COF

Go back to Agios Pharma (AGIO) Misses Q4 EPS by 15c

Agios Pharma (AGIO) PT Raised to $80 at Credit Suisse; 'Platform opportunities beyond IDH'

February 15, 2018 8:59 AM EST

Credit Suisse raised its price target on Agios Pharma (NASDAQ: AGIO) to $80.00 (from $66.00) while maintaining a Outperform rating.

... More

Agios Pharma (AGIO) PT Raised to $90 at Leerink Partners

February 15, 2018 7:33 AM EST

Leerink Partners raised its price target on Agios Pharma (NASDAQ: AGIO) to $90.00 (from $85.00) while maintaining a Outperform rating.

... More

Agios Pharma (AGIO) PT Raised to $86 at Needham & Company; 'Continued Execution'

February 14, 2018 12:48 PM EST

Needham & Company raised its price target on Agios Pharma (NASDAQ: AGIO) to $86.00 (from $72.00) while maintaining a Buy rating.

Analyst Chad Messer commented, " Agios made broad progress across its growing pipeline in 2017 and we expect another busy year with their 2nd drug launch and... More